206 related articles for article (PubMed ID: 18039782)
1. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.
Deboer MD; Zhu X; Levasseur PR; Inui A; Hu Z; Han G; Mitch WE; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL
Endocrinology; 2008 Feb; 149(2):827-35. PubMed ID: 18039782
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.
DeBoer MD; Zhu XX; Levasseur P; Meguid MM; Suzuki S; Inui A; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL
Endocrinology; 2007 Jun; 148(6):3004-12. PubMed ID: 17347304
[TBL] [Abstract][Full Text] [Related]
3. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
[TBL] [Abstract][Full Text] [Related]
4. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
[TBL] [Abstract][Full Text] [Related]
6. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model.
Northrup R; Kuroda K; Duus EM; Barnes SR; Cheatham L; Wiley T; Pietra C
Support Care Cancer; 2013 Sep; 21(9):2409-15. PubMed ID: 23579947
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats.
Strassburg S; Anker SD; Castaneda TR; Burget L; Perez-Tilve D; Pfluger PT; Nogueiras R; Halem H; Dong JZ; Culler MD; Datta R; Tschöp MH
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E78-84. PubMed ID: 18460598
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
Sugiyama M; Yamaki A; Furuya M; Inomata N; Minamitake Y; Ohsuye K; Kangawa K
Regul Pept; 2012 Oct; 178(1-3):21-8. PubMed ID: 22750276
[TBL] [Abstract][Full Text] [Related]
9. Improvement of Physical Decline Through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6Nx CKD Model Mice.
Tamaki M; Hagiwara A; Miyashita K; Wakino S; Inoue H; Fujii K; Fujii C; Sato M; Mitsuishi M; Muraki A; Hayashi K; Doi T; Itoh H
Endocrinology; 2015 Oct; 156(10):3638-48. PubMed ID: 26241123
[TBL] [Abstract][Full Text] [Related]
10. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.
Bresciani E; Rizzi L; Molteni L; Ravelli M; Liantonio A; Ben Haj Salah K; Fehrentz JA; Martinez J; Omeljaniuk RJ; Biagini G; Locatelli V; Torsello A
Endocrine; 2017 Oct; 58(1):106-114. PubMed ID: 27896546
[TBL] [Abstract][Full Text] [Related]
11. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment.
Ali S; Chen JA; Garcia JM
Curr Opin Support Palliat Care; 2013 Dec; 7(4):368-75. PubMed ID: 24145681
[TBL] [Abstract][Full Text] [Related]
12. Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.
Yoshimura M; Shiomi Y; Ohira Y; Takei M; Tanaka T
Eur J Pharmacol; 2017 Sep; 811():30-37. PubMed ID: 28529141
[TBL] [Abstract][Full Text] [Related]
13. A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.
Cheung WW; Ding W; Gunta SS; Gu Y; Tabakman R; Klapper LN; Gertler A; Mak RH
J Am Soc Nephrol; 2014 Jan; 25(1):119-28. PubMed ID: 24115476
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model.
Palus S; Schur R; Akashi YJ; Bockmeyer B; Datta R; Halem H; Dong J; Culler MD; Adams V; Anker SD; Springer J
PLoS One; 2011; 6(11):e26865. PubMed ID: 22102869
[TBL] [Abstract][Full Text] [Related]
15. Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease.
Gortan Cappellari G; Semolic A; Ruozi G; Vinci P; Guarnieri G; Bortolotti F; Barbetta D; Zanetti M; Giacca M; Barazzoni R
FASEB J; 2017 Dec; 31(12):5159-5171. PubMed ID: 28778977
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D ameliorates adipose browning in chronic kidney disease cachexia.
Cheung WW; Ding W; Hoffman HM; Wang Z; Hao S; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Lieber RL; Mak RH
Sci Rep; 2020 Aug; 10(1):14175. PubMed ID: 32843714
[TBL] [Abstract][Full Text] [Related]
17. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
[TBL] [Abstract][Full Text] [Related]
18. Impact of ghrelin on body composition and muscle function in a long-term rodent model of critical illness.
Hill NE; Murphy KG; Saeed S; Phadke R; Chambers D; Wilson DR; Brett SJ; Singer M
PLoS One; 2017; 12(8):e0182659. PubMed ID: 28796827
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease.
Barazzoni R; Zhu X; Deboer M; Datta R; Culler MD; Zanetti M; Guarnieri G; Marks DL
Kidney Int; 2010 Jan; 77(1):23-8. PubMed ID: 19890275
[TBL] [Abstract][Full Text] [Related]
20. On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist.
Salomé N; Hansson C; Taube M; Gustafsson-Ericson L; Egecioglu E; Karlsson-Lindahl L; Fehrentz JA; Martinez J; Perrissoud D; Dickson SL
J Neuroendocrinol; 2009 Sep; 21(9):777-85. PubMed ID: 19703102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
